PA
BEAM icon

Parallel Advisors’s Beam Therapeutics BEAM Stock Holding History

Parallel Advisors’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.33K Hold
97
– – ﹤0.01% 3366
2026
Q1 		$2.31K Hold
97
– – ﹤0.01% 3321
2025
Q4 		$2.69K Hold
97
– – ﹤0.01% 3053
2025
Q3 		$2.35K Hold
97
– – ﹤0.01% 3006
2025
Q2 		$1.65K Sell
97
-18
-16% -$313 ﹤0.01% 3086
2025
Q1 		$2.41K Buy
115
+15
+15% +$393 ﹤0.01% 2922
2024
Q4 		$2.48K Buy
100
+13
+15% +$332 ﹤0.01% 2896
2024
Q3 		$2.13K Buy
87
+1
+1% +$26 ﹤0.01% 2873
2024
Q2 		$2.02K Hold
86
– – ﹤0.01% 2808
2024
Q1 		$2.84K Hold
86
– – ﹤0.01% 2714
2023
Q4 		$2.34K Sell
86
-227
-73% -$5.64K ﹤0.01% 2754
2023
Q3 		$7.53K Buy
313
+300
+2,308% +$8.04K ﹤0.01% 2331
2023
Q2 		$415 Sell
13
-44
-77% -$1.43K ﹤0.01% 3135
2023
Q1 		$1.75K Sell
57
-376
-87% -$14.8K ﹤0.01% 2812
2022
Q4 		$16.9K Buy
433
+395
+1,039% +$17.7K ﹤0.01% 1783
2022
Q3 		$2K Buy
38
+14
+58% +$799 ﹤0.01% 2592
2022
Q2 		$1K Sell
24
-21
-47% -$835 ﹤0.01% 2704
2022
Q1 		$3K Sell
45
-62
-58% -$4.07K ﹤0.01% 2441
2021
Q4 		$9K Buy
107
+88
+463% +$7.54K ﹤0.01% 2141
2021
Q3 		$2K Buy
19
+9
+90% +$904 ﹤0.01% 2650
2021
Q2 		$1K Hold
10
– – ﹤0.01% 2695
2021
Q1 		$1K Hold
10
– – ﹤0.01% 2581
2020
Q4 		$1K Buy
+10
New +$492 ﹤0.01% 2398

Other funds holding BEAM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Parallel Advisors's BEAM Position: Q2 2026 in Review

Parallel Advisors held its Beam Therapeutics (BEAM) position steady in Q2 2026 at 97 shares worth $3.33K. The position accounts for ﹤0.01% of the portfolio, ranked #3366.

Parallel Advisors first reported a position in BEAM in Q4 2020 and has held it in 23 quarters since. The position peaked at $16.9K in Q4 2022. 277 funds tracked by Wall St. Rank hold BEAM as of Q2 2026.

  • Parallel Advisors held 97 shares of Beam Therapeutics worth $3.33K as of Q2 2026.
  • Parallel Advisors left its Beam Therapeutics share count unchanged in Q2 2026.
  • Beam Therapeutics made up ﹤0.01% of Parallel Advisors's portfolio in Q2 2026, its #3366 holding.
  • Parallel Advisors first reported a position in Beam Therapeutics in Q4 2020 and has held it in 23 quarters since.
  • Parallel Advisors's Beam Therapeutics position peaked at $16.9K in Q4 2022.
  • 277 funds tracked by Wall St. Rank held Beam Therapeutics as of Q2 2026.

Based on Parallel Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.